| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41388-018-0475-X |
| P698 | PubMed publication ID | 30171260 |
| P50 | author | Anja Bosserhoff | Q43183440 |
| P2093 | author name string | Claus Hellerbrand | |
| Stephanie Arndt | |||
| Bernd Echtenacher | |||
| David Stieglitz | |||
| Sigrid Karrer | |||
| Silke Kuphal | |||
| Peter Dietrich | |||
| Simone Braig | |||
| Susanne Lamm | |||
| Lena Feuerer | |||
| P2860 | cites work | Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction | Q43295177 |
| Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma | Q45121629 | ||
| Curine inhibits mast cell-dependent responses in mice | Q47629517 | ||
| Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia | Q48250298 | ||
| Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease. | Q51069151 | ||
| Bone Morphogenetic Proteins. | Q51724862 | ||
| Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. | Q53204432 | ||
| Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans? | Q54198017 | ||
| MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. | Q54401832 | ||
| Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases | Q61829328 | ||
| Iron-Induced Expression of Bone Morphogenic Protein 6 in Intestinal Cells Is the Main Regulator of Hepatic Hepcidin Expression In Vivo | Q61829377 | ||
| Bone morphogenetic proteins induce expression of metalloproteinases in melanoma cells and fibroblasts. | Q61829423 | ||
| Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis | Q67983209 | ||
| Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development | Q69123971 | ||
| Bone morphogenetic protein receptors and signal transduction | Q28258965 | ||
| Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma | Q28290954 | ||
| Lack of the bone morphogenetic protein BMP6 induces massive iron overload | Q28510138 | ||
| Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation. | Q30487367 | ||
| AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). | Q33605016 | ||
| p54nrb is a new regulator of progression of malignant melanoma | Q34189944 | ||
| Expression and growth inhibitory effect of decapentaplegic Vg-related protein 6: evidence for a regulatory role in keratinocyte differentiation | Q34291834 | ||
| AllergoOncology: the role of IgE-mediated allergy in cancer | Q34394208 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Histamine in cancer immunotherapy: a preclinical background. | Q34689415 | ||
| Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. | Q35048390 | ||
| Mast cells: the Jekyll and Hyde of tumor growth | Q35751896 | ||
| Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6) | Q36232355 | ||
| Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression | Q36233022 | ||
| Mast cells and cutaneous malignancies | Q36301124 | ||
| Bone Morphogenetic Proteins: A critical review | Q37801468 | ||
| The significant role of mast cells in cancer | Q37834484 | ||
| Mast cells in health and disease | Q37841659 | ||
| BMP-6 inhibits the metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression | Q38804970 | ||
| Strong reduction of AGO2 expression in melanoma and cellular consequences | Q39069039 | ||
| Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance | Q39424150 | ||
| Induction of exportin-5 expression during melanoma development supports the cellular behavior of human malignant melanoma cells | Q39458212 | ||
| Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma | Q39558296 | ||
| MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma | Q39702877 | ||
| Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. | Q39802659 | ||
| Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon | Q40348200 | ||
| Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma | Q41443221 | ||
| BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism | Q41871982 | ||
| Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells | Q41898259 | ||
| Mast cells in cutaneous tumors: innocent bystander or maestro conductor? | Q42437762 | ||
| SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer | Q42881183 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 609-621 | |
| P577 | publication date | 2018-08-31 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | BMP6-induced modulation of the tumor micro-milieu | |
| P478 | volume | 38 |
| Q64994012 | Acidification is an Essential Process of Cold Atmospheric Plasma and Promotes the Anti-Cancer Effect on Malignant Melanoma Cells. |
| Q90044712 | Exosome-mediated uptake of mast cell tryptase into the nucleus of melanoma cells: a novel axis for regulating tumor cell proliferation and gene expression |
| Q90574834 | Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model |
Search more.